Effects of suramin on human lung cancer cell lines
- 31 December 1995
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (2), 244-251
- https://doi.org/10.1016/0959-8049(94)00444-a
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- The effect of schedule, protein binding and growth factors on the activity of suraminInternational Journal of Cancer, 1992
- Suramin, an Active Nonhormonal Cytotoxic Drug for Treatment of Prostate Cancer: Compelling Reasons for Testing in Patients With Hormone-Refractory Breast CancerJNCI Journal of the National Cancer Institute, 1992
- Inhibition of Prostatic Tumor Cell Proliferation by Suramin: Alterations in TGF Alpha-Mediated Autocrine Growth Regulation and Cell Cycle DistributionJournal of Urology, 1991
- Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testingEuropean Journal of Cancer and Clinical Oncology, 1991
- Suramin Blockade of Insulinlike Growth Factor I-Stimulated Proliferation of Human Osteosarcoma CellsJNCI Journal of the National Cancer Institute, 1990
- Epidermal growth factor receptor expression and suramin cytotoxicity in vitroEuropean Journal of Cancer and Clinical Oncology, 1990
- Suramin, an anti‐cancer drug, inhibits protein kinase C and induces differentiation in neuroblastoma cell clone NB2AFEBS Letters, 1989
- Suramin inhibition of growth factor receptor binding and mitogenicity in AKR‐2B cellsJournal of Cellular Physiology, 1987
- Suramin binds to platelet‐derived growth factor and inhibits its biological activityJournal of Cellular Biochemistry, 1985
- Suramin: A potent inhibitor of the reverse transcriptase of RNA tumor virusesCancer Letters, 1979